These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29288094)

  • 1. Mucus-PVPA (mucus Phospholipid Vesicle-based Permeation Assay): An artificial permeability tool for drug screening and formulation development.
    Falavigna M; Klitgaard M; Brase C; Ternullo S; Škalko-Basnet N; Flaten GE
    Int J Pharm; 2018 Feb; 537(1-2):213-222. PubMed ID: 29288094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved permeability of acyclovir: optimization of mucoadhesive liposomes using the phospholipid vesicle-based permeation assay.
    Naderkhani E; Erber A; Škalko-Basnet N; Flaten GE
    J Pharm Sci; 2014 Feb; 103(2):661-8. PubMed ID: 24395733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipid vesicle-based permeation assay and EpiSkin® in assessment of drug therapies destined for skin administration.
    Engesland A; Škalko-Basnet N; Flaten GE
    J Pharm Sci; 2015 Mar; 104(3):1119-27. PubMed ID: 25558045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a biomimetic phospholipid vesicle-based permeation assay for the estimation of intestinal drug permeability.
    Naderkhani E; Isaksson J; Ryzhakov A; Flaten GE
    J Pharm Sci; 2014 Jun; 103(6):1882-90. PubMed ID: 24665049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Vaginal-PVPA: A Vaginal Mucosa-Mimicking In Vitro Permeation Tool for Evaluation of Mucoadhesive Formulations.
    Falavigna M; Pattacini M; Wibel R; Sonvico F; Škalko-Basnet N; Flaten GE
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32575388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of phospholipid vesicle-based permeation assay models capable of evaluating percutaneous penetration enhancing effect.
    Ma M; Di HJ; Zhang H; Yao JH; Dong J; Yan GJ; Qiao HZ; Chen J
    Drug Dev Ind Pharm; 2017 Dec; 43(12):2055-2063. PubMed ID: 28845697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New applications of phospholipid vesicle-based permeation assay: permeation model mimicking skin barrier.
    Engesland A; Skar M; Hansen T; Škalko-Basnet N; Flaten GE
    J Pharm Sci; 2013 May; 102(5):1588-600. PubMed ID: 23529812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mimicking regional and fasted/fed state conditions in the intestine with the mucus-PVPA in vitro model: The impact of pH and simulated intestinal fluids on drug permeability.
    Falavigna M; Klitgaard M; Steene E; Flaten GE
    Eur J Pharm Sci; 2019 Apr; 132():44-54. PubMed ID: 30822502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomes for (trans)dermal drug delivery: the skin-PVPA as a novel in vitro stratum corneum model in formulation development.
    Palac Z; Engesland A; Flaten GE; Škalko-Basnet N; Filipović-Grčić J; Vanić Ž
    J Liposome Res; 2014 Dec; 24(4):313-22. PubMed ID: 24646434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro models to estimate drug penetration through the compromised stratum corneum barrier.
    Engesland A; Škalko-Basnet N; Flaten GE
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1742-51. PubMed ID: 27019078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Oral Absorption of fenofibrate in Lipid-Based Drug Delivery Systems by Combining In Vitro Lipolysis with the Mucus-PVPA Permeability Model.
    Falavigna M; Klitgaard M; Berthelsen R; Müllertz A; Flaten GE
    J Pharm Sci; 2021 Jan; 110(1):208-216. PubMed ID: 32916137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and evaluation of a modified PVPA barrier in comparison to Caco-2 cell monolayers for combined dissolution and permeation testing.
    Gantzsch SP; Kann B; Ofer-Glaessgen M; Loos P; Berchtold H; Balbach S; Eichinger T; Lehr CM; Schaefer UF; Windbergs M
    J Control Release; 2014 Feb; 175():79-86. PubMed ID: 24361370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel human stratum corneum model, as a tool in the optimization of drug formulations.
    Shakel Z; Nunes C; Costa Lima SA; Reis S
    Int J Pharm; 2019 Oct; 569():118571. PubMed ID: 31352050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomimetic PVPA in vitro model for estimation of the intestinal drug permeability using fasted and fed state simulated intestinal fluids.
    Naderkhani E; Vasskog T; Flaten GE
    Eur J Pharm Sci; 2015 Jun; 73():64-71. PubMed ID: 25840125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug permeability across a phospholipid vesicle-based barrier 2. Characterization of barrier structure, storage stability and stability towards pH changes.
    Flaten GE; Bunjes H; Luthman K; Brandl M
    Eur J Pharm Sci; 2006 Jul; 28(4):336-43. PubMed ID: 16697561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Mucin on Drug Diffusion: Development of a Straightforward in Vitro Method for the Determination of Drug Diffusivity in the Presence of Mucin.
    Falavigna M; Stein PC; Flaten GE; di Cagno MP
    Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32079348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs.
    Gonçalves VSS; Matias AA; Poejo J; Serra AT; Duarte CMM
    Int J Pharm; 2016 Dec; 515(1-2):1-10. PubMed ID: 27702697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug permeability profiling using cell-free permeation tools: Overview and applications.
    Berben P; Bauer-Brandl A; Brandl M; Faller B; Flaten GE; Jacobsen AC; Brouwers J; Augustijns P
    Eur J Pharm Sci; 2018 Jul; 119():219-233. PubMed ID: 29660464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier.
    Kanzer J; Tho I; Flaten GE; Mägerlein M; Hölig P; Fricker G; Brandl M
    J Pharm Pharmacol; 2010 Nov; 62(11):1591-8. PubMed ID: 21039543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion.
    Flaten GE; Dhanikula AB; Luthman K; Brandl M
    Eur J Pharm Sci; 2006 Jan; 27(1):80-90. PubMed ID: 16246536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.